Lundbeck CEO expects foundation backing for large acquisitions

If Lundbeck is to stimulate growth, a large-scale acquisition may be one option, the CEO says, though she acknowledges risk must be considered.

Deborah Dunsire, CEO at Lundbeck | Photo: Gregers Tycho/ERH

by torben salomonsen, translated by catherine brett

Published: 12.10.21 at 07:35

Long-term goals are more important than short-term solutions at Lundbeck. After speaking with the CEO, Danish financial daily Børsen reports that if the company wants to grow, a larger acquisition would be a clear option, but in Lundbeck's case, risk is a big concern for the foundation that owns the firm.

"I think that the Lundbeck Foundation would support an acquisition like this if we presented an attractive case that is really a quantum leap for Lundbeck, but we also need to demonstrate that if things don't all go to plan, and the wind is against us, it won't derail the company," says CEO Deborah Dunsire.

Already a subscriber? Log in.

Read the whole article

Get 14 days free access.
No credit card required.

Start a free company trial today

Lundbeck chairman demands change: "We can't live with this"

Years of work developing new treatments at Lundbeck has so far come to nothing. This has led chairman Lars Rasmusssen to demand visible results, even though CEO Deborah Dunsire has essentially had to restart development work since she joined the firm in 2018.